{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T13:43:25Z","timestamp":1787319805330,"version":"build-2736575974"},"reference-count":57,"publisher":"MDPI AG","issue":"24","license":[{"start":{"date-parts":[[2019,12,12]],"date-time":"2019-12-12T00:00:00Z","timestamp":1576108800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Cancer cachexia is a multifactorial syndrome defined by weight loss, muscle wasting, and systemic inflammation. It affects the majority of patients with advanced cancer and is associated with poor treatment response, early mortality and decreased quality of life. The microbiota has been implicated in cancer cachexia through pathways of systemic inflammation, gut barrier dysfunction and muscle wasting. The imbalance of the microbiota, known as dysbiosis, has been shown to influence cancer cachexia. Bacteria that play beneficial and detrimental roles in the disease pathogenesis have been identified. The phenotype of cancer cachexia is associated with decreased levels of Lactobacillales and increased levels of Enterobacteriaceae and Parabacteroides. Currently, there are no treatment options that demonstrate increased survival or the quality of life in patients suffering from cancer cachexia. Through the manipulation of beneficial bacteria in the gut microbiota, different treatment options have been explored. Prebiotics and probiotics have been shown to improve outcomes in animal models of cachexia. Expounding on this mechanism, fecal microbiota transplant (FMT) holds promise for a future treatment of cancer cachexia. Further research is necessary to address this detrimental disease process and improve the lives of patients suffering from cancer cachexia.<\/jats:p>","DOI":"10.3390\/ijms20246267","type":"journal-article","created":{"date-parts":[[2019,12,12]],"date-time":"2019-12-12T11:06:41Z","timestamp":1576148801000},"page":"6267","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":85,"title":["The Microbiota and Cancer Cachexia"],"prefix":"10.3390","volume":"20","author":[{"given":"Kelly M.","family":"Herremans","sequence":"first","affiliation":[{"name":"Department of Surgery, University of Florida College of Medicine, 1600 SW Archer Rd, Room 6165, PO Box 100109, Gainesville, FL 32610, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2088-5400","authenticated-orcid":false,"given":"Andrea N.","family":"Riner","sequence":"additional","affiliation":[{"name":"Department of Surgery, University of Florida College of Medicine, 1600 SW Archer Rd, Room 6165, PO Box 100109, Gainesville, FL 32610, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miles E.","family":"Cameron","sequence":"additional","affiliation":[{"name":"Department of Surgery, University of Florida College of Medicine, 1600 SW Archer Rd, Room 6165, PO Box 100109, Gainesville, FL 32610, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose G.","family":"Trevino","sequence":"additional","affiliation":[{"name":"Department of Surgery, University of Florida College of Medicine, 1600 SW Archer Rd, Room 6165, PO Box 100109, Gainesville, FL 32610, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2019,12,12]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S1470-2045(10)70218-7","article-title":"Definition and Classification of Cancer Cachexia: An International Consensus","volume":"12","author":"Fearon","year":"2011","journal-title":"Lancet Oncol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s13539-013-0111-0","article-title":"Why Cachexia Kills: Examining the Causality of Poor Outcomes in Wasting Conditions","volume":"4","author":"Rhee","year":"2013","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1136\/hrt.24.3.257","article-title":"Diseases of the Heart in the Works of Hippocrates","volume":"24","author":"Katz","year":"1962","journal-title":"Br. Heart J."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1200\/JOP.2016.016832","article-title":"Cancer Cachexia: Beyond Weight Loss","volume":"12","author":"Bruggeman","year":"2016","journal-title":"J. Oncol. Pract."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1093\/annonc\/mdw604","article-title":"Causes of Death among Cancer Patients","volume":"28","author":"Zaorsky","year":"2017","journal-title":"Ann. Oncol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/nrclinonc.2012.209","article-title":"Understanding the mechanisms and treatment options in cancer cachexia","volume":"10","author":"Fearon","year":"2012","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"67","DOI":"10.21037\/apm.2018.07.06","article-title":"Anti-cytokines in the treatment of cancer cachexia","volume":"8","author":"Prado","year":"2019","journal-title":"Ann. Palliat. Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1038\/sj.embor.7400731","article-title":"The Gut Flora as a Forgotten Organ","volume":"7","author":"Shanahan","year":"2006","journal-title":"EMBO Rep."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"j5145","DOI":"10.1136\/bmj.j5145","article-title":"The role of the gut microbiome in systemic inflammatory disease","volume":"36","author":"Clemente","year":"2018","journal-title":"BMJ"},{"key":"ref_10","first-page":"5","article-title":"Metagenomics, Metatranscriptomics, and Metabolomics Approaches for Microbiome Analysis","volume":"12","author":"Huang","year":"2016","journal-title":"Evol. Bioinform."},{"key":"ref_11","first-page":"800","article-title":"The Microbiome and Cancer. Nature reviews","volume":"13","author":"Schwabe","year":"2013","journal-title":"Cancer"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1158\/1940-6207.CAPR-16-0249","article-title":"The Human Microbiome and Cancer","volume":"10","author":"Rajagopala","year":"2017","journal-title":"Cancer Prev. Res."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1136\/gutjnl-2017-314814","article-title":"The Oral Microbiota in Colorectal Cancer is Distinctive and Predictive","volume":"67","author":"Flemer","year":"2018","journal-title":"Gut"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1007\/s00248-013-0345-6","article-title":"Molecular Characterization of Skin Microbiota between Cancer Cachexia Patients and Healthy Volunteers","volume":"67","author":"Li","year":"2014","journal-title":"Microb. Ecol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1002\/ijc.31098","article-title":"Difference of Lower Airway Microbiome in Bilateral Protected Specimen Brush between Lung Cancer Patients with Unilateral Lobar Masses and Control Subjects","volume":"142","author":"Liu","year":"2018","journal-title":"Int. J. Cancer"},{"key":"ref_16","first-page":"128","article-title":"The Urinary Tract Microbiome in Health and Disease","volume":"4","author":"Castillo","year":"2016","journal-title":"Eur. Urol. Focus"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/1471-0528.14631","article-title":"The Role of the Vaginal Microbiome in Gynaecological Cancer","volume":"125","author":"Champer","year":"2018","journal-title":"BJOG"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/nrgastro.2017.20","article-title":"Gut microbiota modulation of chemotherapy efficacy and toxicity","volume":"14","author":"Alexander","year":"2017","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1111\/apt.13302","article-title":"Chemotherapy-driven dysbiosis in the intestinal microbiome","volume":"42","author":"Montassier","year":"2015","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1016\/j.biocel.2013.06.021","article-title":"Muscle Wasting: The Gut Microbiota as a New Therapeutic Target?","volume":"45","author":"Bindels","year":"2013","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1038\/nrc3829","article-title":"Cancer Cachexia: Understanding the Molecular Basis","volume":"14","author":"Busquets","year":"2014","journal-title":"Nat. Rev. Cancer"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.lfs.2016.11.033","article-title":"TNF-A and Cancer Cachexia: Molecular Insights and Clinical Implications","volume":"170","author":"Patel","year":"2017","journal-title":"Life Sci."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"3071","DOI":"10.1007\/s00520-013-1878-4","article-title":"Interleukin-6 but not tumour necrosis factor-alpha predicts survival in patients with advanced cancer","volume":"11","author":"Suh","year":"2013","journal-title":"Support Care Cancer"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/SPC.0000000000000091","article-title":"Role of IL-6 in Cachexia\u2013Therapeutic Implications","volume":"8","author":"Narsale","year":"2014","journal-title":"Curr. Opin. Supportive Palliat. Care"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"4940","DOI":"10.1096\/fj.13-233528","article-title":"Ubiquitin-specific protease 2-69 in macrophages potentially modulates metainflammation","volume":"27","author":"Kitamura","year":"2013","journal-title":"FASEB"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.2337\/db07-1403","article-title":"Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice","volume":"57","author":"Cani","year":"2008","journal-title":"Diabetes"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1038\/nri2449","article-title":"Nutrient sensing and inflammation in metabolic diseases","volume":"8","author":"Hotamisligil","year":"2008","journal-title":"Nat. Rev. Immunol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"2823","DOI":"10.1007\/s00125-012-2648-4","article-title":"Modulation of gut microbiota by antibiotics improves insulin signalling in high-fat fed mice","volume":"55","author":"Carvalho","year":"2012","journal-title":"Diabetologia"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.phrs.2012.10.007","article-title":"Modulation of Intestinal Barrier by Intestinal Microbiota: Pathological and Therapeutic Implications","volume":"69","author":"Natividad","year":"2013","journal-title":"Pharmacol. Res."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"261","DOI":"10.14740\/gr1053w","article-title":"The Role of the Gut Barrier Function in Health and Disease","volume":"11","author":"Assimakopoulos","year":"2018","journal-title":"Gastroenterol. Res."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/cmi.2010.67","article-title":"The Role of Gut Microbiota (Commensal Bacteria) and the Mucosal Barrier in the Pathogenesis of Inflammatory and Autoimmune Diseases and Cancer: Contribution of Germ-Free and Gnotobiotic Animal Models of Human Diseases","volume":"8","author":"Hudcovic","year":"2011","journal-title":"Cell. Mol. Immunol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/SPC.0b013e32835f3e8c","article-title":"Chemotherapy-Induced Mucosal Barrier Dysfunction: An Updated Review on the Role of Intestinal Tight Junctions","volume":"7","author":"Wardill","year":"2013","journal-title":"Curr. Opin. Supportive Palliat. Care"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/nprot.2007.41","article-title":"Chemically Induced Mouse Models of Intestinal Inflammation","volume":"2","author":"Weigmann","year":"2007","journal-title":"Nat. Protoc."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1172\/JCI113938","article-title":"Interferon-Gamma Directly Affects Barrier Function of Cultured Intestinal Epithelial Monolayers","volume":"83","author":"Madara","year":"1989","journal-title":"J. Clin. Investig."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1097\/SPC.0000000000000017","article-title":"Gut Barrier Dysfunction and Microbial Translocation in Cancer Cachexia: A New Therapeutic Target","volume":"7","author":"Klein","year":"2013","journal-title":"Curr. Opin. Supportive Palliat. Care"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1016\/j.bbadis.2011.08.010","article-title":"Gut Barrier Dysfunction in the ApcMin\/+ Mouse Model of Colon Cancer Cachexia","volume":"1812","author":"Puppa","year":"2011","journal-title":"Biochim. Et Biophys. Acta"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1089\/jir.2013.0020","article-title":"The Altered Tight Junctions: An Important Gateway of Bacterial Translocation in Cachexia Patients with Advanced Gastric Cancer","volume":"34","author":"Jiang","year":"2014","journal-title":"J. Interferon Cytokine Res."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"18224","DOI":"10.18632\/oncotarget.24804","article-title":"Increased gut permeability in cancer cachexia: Mechanisms and clinical relevance","volume":"9","author":"Bindels","year":"2018","journal-title":"Oncotarget"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1152\/ajpendo.00521.2018","article-title":"Gut bacteria are critical for optimal muscle function: A potential link with glucose homeostasis","volume":"1","author":"Nay","year":"2019","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1152\/ajpregu.00039.2002","article-title":"Lipopolysaccharide Regulates Proinflammatory Cytokine Expression in Mouse Myoblasts and Skeletal Muscle","volume":"283","author":"Frost","year":"2002","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1152\/japplphysiol.01026.2004","article-title":"IL-6-Induced Skeletal Muscle Atrophy","volume":"98","author":"Haddad","year":"2005","journal-title":"J. Appl. Physiol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1096\/fj.04-2364com","article-title":"TNF-A Acts Via p38 MAPK to Stimulate Expression of the Ubiquitin Ligase Atrogin1\/MAFbx in Skeletal Muscle","volume":"19","author":"Li","year":"2005","journal-title":"FASEB J."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s00223-017-0345-5","article-title":"Gut Microbiota Contribute to Age-Related Changes in Skeletal Muscle Size, Composition, and Function: Biological Basis for a Gut-Muscle Axis","volume":"102","author":"Grosicki","year":"2018","journal-title":"Calcif. Tissue Int."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1126\/science.1110591","article-title":"Diversity of the Human Intestinal Microbial Flora","volume":"308","author":"Eckburg","year":"2005","journal-title":"Science"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.1158\/1055-9965.EPI-08-0792","article-title":"The Human Microbiome Project: Getting to the Guts of the Matter in Cancer Epidemiology","volume":"17","author":"Lampe","year":"2008","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"ref_46","first-page":"979","article-title":"Mechanisms underlying the resistance to diet-induced obesity in germ-free mice","volume":"3","author":"Manchester","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Bindels, L.B., Beck, R., Schakman, O., Martin, J.C., De Backer, F., Sohet, F.M., Dewulf, E.M., Pachikian, B.D., Neyrinck, A.M., and Thissen, J. (2012). Restoring Specific Lactobacilli Levels Decreases Inflammation and Muscle Atrophy Markers in an Acute Leukemia Mouse Model. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0037971"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1038\/ismej.2015.209","article-title":"Synbiotic Approach Restores Intestinal Homeostasis and Prolongs Survival in Leukaemic Mice with Cachexia","volume":"10","author":"Bindels","year":"2016","journal-title":"ISME J."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"12321","DOI":"10.1038\/s41598-018-30569-5","article-title":"Klebsiella Oxytoca Expands in Cancer Cachexia and Acts as a Gut Pathobiont Contributing to Intestinal Dysfunction","volume":"8","author":"Brossel","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"S58","DOI":"10.1086\/523341","article-title":"Probiotics: Definition, Sources, Selection, and Uses","volume":"46","author":"Sanders","year":"2008","journal-title":"Clin. Infect. Dis."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"11803","DOI":"10.18632\/oncotarget.7730","article-title":"Beneficial Bacteria Inhibit Cachexia","volume":"7","author":"Varian","year":"2016","journal-title":"Oncotarget"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1093\/annonc\/mdu106","article-title":"The Efficacy and Safety of Probiotics in People with Cancer: A Systematic Review","volume":"25","author":"Redman","year":"2014","journal-title":"Ann. Oncol."},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Bindels, L.B., Neyrinck, A.M., Salazar, N., Taminiau, B., Druart, C., Muccioli, G.G., Fran\u00e7ois, E., Blecker, C., Richel, A., and Daube, G. (2015). Non Digestible Oligosaccharides Modulate the Gut Microbiota to Control the Development of Leukemia and Associated Cachexia in Mice. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0131009"},{"key":"ref_54","first-page":"1","article-title":"Ginsenosides Rb3 and Rd Reduce Polyps Formation while Reinstate the Dysbiotic Gut Microbiota and the Intestinal Microenvironment in ApcMin\/+ Mice","volume":"7","author":"Huang","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"257","DOI":"10.5946\/ce.2015.117","article-title":"Fecal Microbiota Transplantation: Current Applications, Effectiveness, and Future Perspectives","volume":"49","author":"Choi","year":"2016","journal-title":"Clin. Endosc."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/j.ebiom.2019.03.070","article-title":"Adjunctive Fecal Microbiota Transplantation in Supportive Oncology: Emerging Indications and Considerations in Immunocompromised Patients","volume":"44","author":"Wardill","year":"2019","journal-title":"EBioMedicine"},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Wang, S., Xu, M., Wang, W., Cao, X., Piao, M., Khan, S., Yan, F., Cao, H., and Wang, B. (2016). Systematic Review: Adverse Events of Fecal Microbiota Transplantation. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0161174"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/20\/24\/6267\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:41:44Z","timestamp":1760190104000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/20\/24\/6267"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,12]]},"references-count":57,"journal-issue":{"issue":"24","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["ijms20246267"],"URL":"https:\/\/doi.org\/10.3390\/ijms20246267","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,12]]}}}